Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with pancreatic cancer
Issued Date
2025-10-01
Resource Type
eISSN
20597029
Scopus ID
2-s2.0-105018206677
Journal Title
ESMO Open
Volume
10
Issue
10
Rights Holder(s)
SCOPUS
Bibliographic Citation
ESMO Open Vol.10 No.10 (2025)
Suggested Citation
Tai D., Conroy T., Lee J.J.X., Chee C.E., Hao C.Y., Wijaya I., Aggarwal S., Ueno M., Jeung H.C., Hashim N.M., Tan Chun Bing J., Chen L.T., Korphaisarn K., Tanasanvimon S., Chou W.C., Cargullo E., Muin N.F.A., Lee M.A., Ohba A., Bondarde S., Lesmana C.R.A., Wang L., Smyth E.C., Yoshino T., Bonney G., Pentheroudakis G., Samol J., Cervantes A., Poon E., Ducreux M. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with pancreatic cancer. ESMO Open Vol.10 No.10 (2025). doi:10.1016/j.esmoop.2025.105826 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/112636
Title
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with pancreatic cancer
Author(s)
Tai D.
Conroy T.
Lee J.J.X.
Chee C.E.
Hao C.Y.
Wijaya I.
Aggarwal S.
Ueno M.
Jeung H.C.
Hashim N.M.
Tan Chun Bing J.
Chen L.T.
Korphaisarn K.
Tanasanvimon S.
Chou W.C.
Cargullo E.
Muin N.F.A.
Lee M.A.
Ohba A.
Bondarde S.
Lesmana C.R.A.
Wang L.
Smyth E.C.
Yoshino T.
Bonney G.
Pentheroudakis G.
Samol J.
Cervantes A.
Poon E.
Ducreux M.
Conroy T.
Lee J.J.X.
Chee C.E.
Hao C.Y.
Wijaya I.
Aggarwal S.
Ueno M.
Jeung H.C.
Hashim N.M.
Tan Chun Bing J.
Chen L.T.
Korphaisarn K.
Tanasanvimon S.
Chou W.C.
Cargullo E.
Muin N.F.A.
Lee M.A.
Ohba A.
Bondarde S.
Lesmana C.R.A.
Wang L.
Smyth E.C.
Yoshino T.
Bonney G.
Pentheroudakis G.
Samol J.
Cervantes A.
Poon E.
Ducreux M.
Author's Affiliation
Inserm
National University of Singapore
Johns Hopkins University
Université Paris-Saclay
Universitat de València
Université de Lorraine
Instituto de Salud Carlos III
Chang Gung University College of Medicine
Renji Hospital
Universitas Padjadjaran
Kaohsiung Medical University Chung-Ho Memorial Hospital
Siriraj Hospital
National University Hospital
The Catholic University of Korea Seoul St. Mary's Hospital
National University Health System
Tan Tock Seng Hospital
Beijing Cancer Hospital
Lee Kong Chian School of Medicine
National Cancer Center Hospital East
Gangnam Severance Hospital
NIHR Oxford Biomedical Research Centre
Universitas Indonesia, RSUPN Dr. Cipto Mangunkusumo
Faculty of Medicine, Chulalongkorn University
National Cancer Centre, Singapore
Hospital Canselor Tuanku Muhriz UKM
Shizuoka Cancer Center
Kanagawa Cancer Center Research Institute
Sir Ganga Ram Hospital
Department of Medicine
National Institute of Cancer Research
University of Perpetual Help System DALTA
KPJ Johor Specialist Hospital
ESMO
Apex Wellness Hospital
Vincente Gullas Memorial Hospital
National University of Singapore
Johns Hopkins University
Université Paris-Saclay
Universitat de València
Université de Lorraine
Instituto de Salud Carlos III
Chang Gung University College of Medicine
Renji Hospital
Universitas Padjadjaran
Kaohsiung Medical University Chung-Ho Memorial Hospital
Siriraj Hospital
National University Hospital
The Catholic University of Korea Seoul St. Mary's Hospital
National University Health System
Tan Tock Seng Hospital
Beijing Cancer Hospital
Lee Kong Chian School of Medicine
National Cancer Center Hospital East
Gangnam Severance Hospital
NIHR Oxford Biomedical Research Centre
Universitas Indonesia, RSUPN Dr. Cipto Mangunkusumo
Faculty of Medicine, Chulalongkorn University
National Cancer Centre, Singapore
Hospital Canselor Tuanku Muhriz UKM
Shizuoka Cancer Center
Kanagawa Cancer Center Research Institute
Sir Ganga Ram Hospital
Department of Medicine
National Institute of Cancer Research
University of Perpetual Help System DALTA
KPJ Johor Specialist Hospital
ESMO
Apex Wellness Hospital
Vincente Gullas Memorial Hospital
Corresponding Author(s)
Other Contributor(s)
Abstract
The European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with pancreatic cancer, published in November 2023, were adapted in December 2024, according to previously established standard methodology, to produce the Pan-Asian adapted (PAGA) ESMO consensus guidelines for the management of Asian patients with pancreatic cancer. The adapted guidelines presented in this manuscript represent the consensus opinions reached by a panel of Asian experts in the treatment of patients with pancreatic cancer representing the oncological societies of China (CSCO), Indonesia (ISHMO), India (ISMPO), Japan (JSMO), Korea (KSMO), Malaysia (MOS), the Philippines (PSMO), Singapore (SSO), Taiwan (TOS) and Thailand (TSCO), co-ordinated by ESMO and the Singapore Society of Oncology (SSO). The voting was based on scientific evidence and was independent of the current treatment practices, drug access restrictions and reimbursement decisions in the different regions of Asia. The latter are discussed separately in the manuscript. The aim is to provide guidance for the optimisation and harmonisation of the management of patients with pancreatic cancer across the different countries of Asia, drawing on the evidence provided by both Western and Asian trials. Attention is drawn to the disparity in drug approvals and reimbursement strategies between the different countries.